Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

It’s in trial until the data is locked. The data isn’t locked until there is nothing more to input. Unblinding does not take place until after data lock.

Double and triple checking outcome measures delays data lock because once locked no data can change in any way. There is most likely a trial audit underway to confirm all data points from over 30 clinical sites. That means actually visiting the sites to assess data collected and procedures followed for the protocol.

CEOs of biopharmas never discuss this, at least in my 20 years experience I’ve never run across a CEO who presented anything but final outcomes. Company officials can’t even include any data prior to lock (and unblinding) at conferences due to rules against presentations for drug outcomes of drug trials still underway, meaning prior to data lock.

That’s just the way it is.